Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT Inhibition in Diabetic Cardiomyopathy
NCT04200586Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in diabetic cardiomyopathy (DCM), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
diabetic cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT04200586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200586.